// . //  Industries // Health And Life Sciences

What We Do

Our innovative thinking and strategic advice helps clients in the payer, provider, digital health, and life sciences sectors realize their most ambitious organizational and operational visions by bridging the gap between their business today and their vision for the future.

At Oliver Wyman, we are focused on creating positive change in healthcare, but we know we can’t do it all ourselves. Together, with today's leading healthcare experts and innovators, we’ve built a community to share and shape ideas that will transform healthcare. We work to ensure industry transformation through generating meaningful client impact, delivering strategic insights, and creating a healthcare system that meets the needs of communities and companies.  


What We Think

Future Truths: Inevitable and Inspiring

Health Innovation Journal Volume 4

Read more

Decoding Our Future

How the industry will evolve over the next 10 years.

Read more

Data sharing will come of age

Access will become commoditized.

Read more

Health On Demand

A report on digital health solutions in the US workplace

Read more

Learned Lessons Amidst COVID-19

When COVID forced change, health systems learned these lessons

Read more


Read through the case for change and potential archetypes of the future

Read more

Is It Time For A Digital-Only System?

Part 1: Reassessing physical needs in a virtual world

Read more

Leading in Uncertain Times

Gordon Rudow discusses three ways leaders can transform anxiety into empathy with host Sam Glick

Read more

How Will COVID-19 Unfold?

The first half of 2020 was marked by the emergence of COVID-19 and its rapid global spread

Read more

Who We Are



Health Insurance Mix Shift Modeling

Our model helps clients understand the impact of high unemployment rates on the future health insurance mix

Pandemic Navigator

Pandemic forecasts and scenarios connected to economic and business outcomes

COVID-19 Almanac

A central COVID-19 almanac covering the latest status from an epidemiologic perspective, the key scenarios that can play out over time, and core considerations as economies reopen